L-Arginine Plus 13
Natural health product licensed in Canada
- Licence holder
- Jimara Limited
- NPN or DIN-HM
- 80084197
- Status
- Active licence
- Licence date
- 3 April 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Epimedium sagittatum Source : Sommité Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 1,750 mg Potency : 10 % Icariin | 70 mg | Not calculated |
| Eurycoma longifolia Source : Racine Extract : Matériel brut sec Extraction ratio : 100:1 Dry plant equivalent : 3,400 mg | 34 mg | Not calculated |
| L-arginine Source : Monohydrochlorure de L-arginine | 100 mg | Not calculated |
| Tribulus terrestris Source : Fruit | 35 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of (an) amino acid(s) involved in muscle protein synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you suffer from a hormone-sensitive condition, anxiety, depression, a psychological disorder, high blood pressure, diabetes, a bleeding disorder, or if you have ulcerative colitis, Crohn's disease or hemorrhoids. Consult a health care practitioner prior to use if you are trying to conceive or if you are taking propranolol. Ensure to drink enough fluid before, during, and after exercise. If symptoms persist or worsen, or if new symptoms develop, consult a health care practitioner. If you have hypertension or are taking medication(s) for hypertension, consult a health care practitioner prior to use. Do not use if you have fire from yin deficiency. Consult a healthcare practitioner prior to use if you have benign prostate hypertrophy and/or prostate cancer. Adult women: Consult a healthcare practitioner if you experience abnormal hair growth.
Source
Official Health Canada record, licence 80084197
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.